| High midnight salivary cortisol (≥9.3 nmol/L) | ||||
---|---|---|---|---|---|
 | COR (95% CI) | P1 | AOR (95% CI) | P2 | |
Smoking | 5.5 (1.9–16.1) | 0.002 | 5.5 (1.6–18.5) | 0.006 | |
Age (per year) | 1.06 (1.02–1.10) | 0.002 | 1.08 (1.03–1.13) | 0.001 | |
Season | Â | Â | Â | Â | |
Spring | 4.2 (1.5–11.9) | 0.007 | 4.3 (1.4–13.7) | 0.013 | |
Summer | 2.7 (0.9–8.7) | 0.09 | 3.4 (0.9–13.0) | 0.07 | |
Autumn/winter (reference) | 1 | Â | 1 | Â | |
Physical inactivity | 3.0 (1.1–8.3) | 0.036 | 3.9 (1.1–13.4) | 0.032 | |
Depression | 4.9 (1.9–13.1) | 0.001 | 3.1 (1.0–9.2) | 0.047 | |
Women | 1.2 (0.6–2.6) | 0.66 | 2.2 (0.9–5.2) | 0.089 | |
Antidepressants | 2.3 (0.7–7.8) | 0.20 | - | 0.76 | |
Inhaled steroids | 0.3 (0.04–2.5) | 0.28 | - | - | |
Diabetes duration | 1.01 (0.98–1.04) | 0.40 | - | - | |
HbA1c | mmol/mol (per unit) | 1.01 (0.98–1.04) | 0.57 | - | - |
% (per unit) | 1.10 (0.80–1.51) | ||||
Abdominal obesity, men | 0.7 (0.1–6.2) | 0.76 | - | - | |
Abdominal obesity, women | 0.9 (0.3–3.3) | 0.92 | - | - |